PE/VC, IPO and Transaction Valuations

Part of the Complex Business Valuations pillar.

Why transaction valuations deserve more care than they often get

A transaction valuation is the most commercially pointed form of valuation work: the output drives the pricing of a live deal, the regulatory filing that follows, and, if the transaction is disputed years later, the defence of the pricing decision. Yet transaction valuations are frequently performed under schedule pressure, with incomplete diligence, by valuers who are not structurally independent from the deal process.

The consequences compound. A DCF anchored to an optimistic forecast inflates the valuation; the deal gets priced on that forecast; the forecast misses; the investor sues under the warranty regime. A comparable-multiple analysis that cherry-picks favourable peers produces a number that tax authorities or regulators subsequently challenge. In each case, the valuation becomes the weakest link in the chain, not because valuation is inherently unreliable, but because the specific valuation was not built to withstand the scrutiny it would later face.

This note sets out how to commission, structure and scrutinise transaction valuations so they hold up.

The three transaction contexts and how they differ

PE and VC round valuations anchor private-market investment rounds. The audience is the investor’s investment committee, the company’s existing shareholders, and the lawyers drafting the SHA. The standard is fair market value, but the methodology has to satisfy regulatory pricing requirements under RBI’s FEMA rules (for foreign investors), Section 56(2) and Rule 11UA (for Income tax), and, if the investor is a SEBI-regulated AIF, its internal valuation policy and IPEV valuation guidelines. A typical VC or PE valuation uses the market approach (comparable transactions and comparable companies) as the primary method, supplemented by the income approach (DCF on the forward business plan) as a cross-check. Early-stage valuations often use revenue multiples; growth-stage and PE valuations use forward EBITDA multiples; very early-stage deals may use scorecard or Berkus methods.

IPO valuations anchor the public-market offering. The primary decision-makers are the merchant bankers running the book, the promoter, and the institutional investors placing anchor and IPO demand. Regulation is intense: SEBI ICDR requires disclosure of the WACA of shares allotted in the 18 months prior to listing. The methodology typically combines listed peer benchmarking and often precedent IPO pricing in the same sector. Valuation in the IPO context is a negotiation: merchant bankers push for marketable pricing, promoters push for valuation retention, and regulators require defensible backing while approving DRHP’s.

Transaction valuations for M&A anchor the pricing of an acquisition or divestment. Here the complexity multiplies: the valuation must reflect the standalone value of the target, the synergies specific to the acquirer, the risks specific to the transaction (integration execution, key-person retention, legal overhangs), and the structuring-driven tax effects. Multiple valuations are often prepared: a standalone valuation for the target, a synergised valuation for the acquirer’s willingness-to-pay, and a fair-market-value-based valuation for regulatory and tax compliance.

Methodology: the disciplines that matter

Selection of valuation approaches. International Valuation Standards require the valuer to consider all approaches and select those most relevant to the specific asset and purpose. For an operating business, the income and market approaches are both relevant; the asset approach is usually a floor, not a primary method. The written rationale for the selection is itself audit-critical.

Forecast construction for DCF. The forecast should tie to the management business plan, but the valuer must assess the plan for reasonableness. Historical performance analysis, industry benchmarking, capacity constraints, working-capital modelling and explicit capex scheduling all matter. A common failure mode is a forecast with rapid revenue growth, expanding margins and minimal capex and working capital simultaneously; this triple-optimism should flag immediately and either be substantiated or stress-tested.

Discount rate. The WACC should be built from observable inputs: risk-free rate from current 10-year G-Sec yields, equity risk premium from empirical studies for India (typically in the 6 to 7 percent range, based on Damodaran’s annually updated estimates), beta from comparable listed peers (relevered to the subject’s capital structure), size premium (for mid-market companies, typically 2 to 4 percent), and company-specific risk premium where justified by specific risk factors. The discount rate should NOT be a round number plucked from intuition; every component should be sourced, dated and sensitised.

Terminal value. The terminal value often accounts for 60 to 80 percent of DCF value, so its construction matters disproportionately. The perpetuity growth rate must be consistent with long-term nominal GDP growth (for India, typically 4 percent). Exit-multiple terminal values should be consistent with trading multiples of mature listed peers. Cross-checking the implied exit multiple against observed listed-peer multiples is standard discipline; a terminal value implying an exit multiple far above listed peer trading is a red flag.

Comparable companies. Peer selection should be explicit and written: what industry, what business model, what size range, what margin profile, what geographic exposure qualifies a company as a peer. The adjustments applied — for size, growth, margin, growth sustainability — should be explicit. Median multiples recommended to avoid outliers. Application of the multiple should be to the financial metric consistent with the multiple source.

Comparable transactions. Precedent transaction analysis requires dated, documented transactions with sufficient detail to compute meaningful multiples. Transactions older than 12 months should be cautiously considered, adjusting for market-condition changes. Control premiums embedded in transaction multiples must be adjusted if the subject valuation is for a minority stake, and vice versa.

Marketability and control discounts. An illiquidity discount of 15 to 20 percent is conventional for unlisted-company valuations where the market approach relies on listed peers; a larger discount applies for earlier-stage companies with no credible exit pathway. Control premiums of 20 to 30 percent apply when valuing a controlling stake from minority-anchored comparables. Each adjustment should be sourced to empirical studies rather than invoked as convention.

Regulatory compliance: the specific technical requirements

RBI / FEMA: For foreign investment into an Indian company, the pricing must be at or above the fair value determined by a SEBI-registered Merchant Banker or a Chartered Accountant, using any internationally accepted pricing methodology (typically DCF). For a foreign investor exiting an Indian company, pricing must be at or below the fair value, determined similarly. The Form FC-GPR (for issue) and FC-TRS (for transfer) filings require the valuation report as an attachment.

Income Tax Act Section 56(2)(x) and Rule 11UA: For share allotments by an Indian Company (only to Non Residents) or transfers (to any person), the FMV under Rule 11UA must be determined, and consideration below FMV creates deemed-income tax. Rule 11UA provides specific methodologies — Book Value Method, DCF Method under prescribed parameters.

SEBI Preferential Allotment: For preferential allotments by listed companies, pricing must be at or above the higher of the average of the last 90 trading days  or 10 trading days volume weighted average price (VWAP) (for frequently traded shares), or a fair value determined by a registered valuer (for infrequently traded shares). The valuation must consider three methods — NAV, Income and market price / comparable companies multiples — and disclose the rationale for the final conclusion.

Further, any preferential issue, which may result in a change in control or allotment of more than five per cent of the post issue fully diluted share capital of the issuer, to an allottee or to allottees acting in concert, shall require a valuation report from an independent registered valuer and consider the same for determining the price:

The floor price, in such cases, shall be higher of the floor price determined under sub regulation (1), (2) or (4) of regulation 164, as the case may be, or the price determined under the valuation report from the independent registered valuer or the price determined in accordance with the provisions of the Articles of Association of the issuer, if applicable:

Provided further that if any proposed preferential issue is likely to result in a change in control of the issuer, the valuation report from the registered valuer shall also cover guidance on control premium, which shall be computed over and above the price determined in terms of the first proviso:

Documentation: what a defensible report contains

A transaction valuation report should contain, at minimum: scope of engagement (purpose, valuation date, standard of value, premise of value), description of the subject entity, macro and industry analysis, historical financial analysis, forecast analysis with explicit driver-based build-up, methodology selection with rationale, detailed application of each selected methodology, reconciliation across methodologies, sensitivity analysis on the two or three most critical assumptions, conclusion, and a full appendix with sources, workings and data trails.

A valuation report that opens with two paragraphs and closes with a number is not defensible. Reports that survive tax scrutiny, auditor review or regulatory challenge typically run 25 to 50 pages for substantive valuations, with supporting workpapers that substantially exceed the report.

The Companies (Registered Valuers and Valuation) Rules, 2017 provide for contents of a valuation report and disclosures. Reports that do not comply with these Rules are increasingly flagged by IBBI and regulators as non-conforming.

The commercial reality: what actually drives the negotiation

A common misperception is that the valuation report determines the deal price. In practice, the deal price is negotiated between commercial parties based on their respective willingness-to-pay and willingness-to-accept, and the valuation is structured to support the negotiated price.

This is legitimate when the valuation methodology genuinely supports the negotiated outcome within a reasonable range. A DCF with moderately optimistic but defensible assumptions, combined with a market approach anchored to appropriately-selected peers, can support a range of valuations — and the report explains that range with specific sensitivity analysis.

It becomes illegitimate when the methodology is tortured to reach a pre-determined number — unrealistically high growth rates, implausibly low discount rates, cherry-picked peer sets, selective application of control premiums or discounts. Reports built this way survive short-term but fail when scrutinised later.

The advisory discipline is therefore to structure the engagement so the valuer has genuine independence from the deal economics. Fees should not be contingent on transaction completion (Valuation standards prohibit this).

Final perspective

Transaction valuations are the public face of valuation work. They appear in term sheets, DRHPs, scheme petitions, regulatory filings, investor presentations and news stories. Their quality signals the company’s governance; their weaknesses invite scrutiny. Commissioning them well — with adequate scope, appropriate methodology, clean independence, thorough documentation and a valuer whose credibility withstands challenge — is both a transaction-level discipline and a long-term reputational investment.

GDPR